TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM NEW
Total 13F shares
6,958,612
Share change
-52,891
Total reported value
$40,344,367
Price per share
$5.80
Number of holders
25
Value change
-$310,482
Number of buys
7
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q3 2018

As of 30 Sep 2018, TRILLIUM THERAPEUTICS INC - COM NEW was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,958,612 shares. The largest 10 holders included Matrix Capital Management Company, LP, NEA Management Company, LLC, AWM Investment Company, Inc., BAKER BROS. ADVISORS LP, Cormorant Asset Management, LP, Tekla Capital Management LLC, MORGAN STANLEY, PLATINUM INVESTMENT MANAGEMENT LTD, Artal Group S.A., and Stanley-Laman Group, Ltd.. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.